Zobrazeno 1 - 8
of 8
pro vyhledávání: '"T M M H de By"'
Autor:
M Ondrusek, P. Artemiou, I. Gasparovic, T M M H de By, V Hudec, P Lesny, Christiaan F J Antonides, Jan Gummert, E Goncalvesova, Felix Schönrath, M. Hulman
Publikováno v:
Bratislava Medical Journal, 122(6), 371-378. Comenius University
OBJECTIVES: Mechanical circulatory support is an established therapy in end-stage heart failure. The EUROMACS registry was created to promote research in these patients. The aim of this report was to present our 12 year experience with the durable me
Autor:
Markus M. Luedi, Stephan Dobner, M Fuerholz, Thierry Carrel, T M M H de By, Lukas Hunziker, David Reineke, Paul Mohacsi, Joerg C. Schefold, Patrick Schober, P.P. Heinisch, Maks Mihalj, Beate Hugi-Mayr, Alexander Kadner, Michele Martinelli
Publikováno v:
European Heart Journal, 42, 946-946. Oxford University Press
Background Continuous-flow left ventricular assist devices (CF-LVADs) have become a standard of care in end-stage heart failure (HF). Device-related complications remain high. Limited data exists comparing outcomes of the HeartMate 3 (HM3) and the He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8200e0d0e5bb2f64f2739ad93f7647a2
https://research.vumc.nl/en/publications/89baaaab-7335-45de-8653-469c0866f790
https://research.vumc.nl/en/publications/89baaaab-7335-45de-8653-469c0866f790
Autor:
B Merkely, T M M H de By, Bart Meyns, Christiaan F J Antonides, P. Nemec, Ad J.J.C. Bogers, Jan Gummert, Felix Schoenrath, Kadir Caliskan, C. Zijderhand, Kevin M Veen, Francesco Musumeci
Publikováno v:
European Heart Journal. 42
Background In patients supported by a ventricular assist device (VAD) major infections are a frequently reported adverse event with increased morbidity and mortality. Purpose The purpose of this study was to investigate the possible association betwe
Autor:
E. S. J. Kalter, T. M. M. H. De By
Publikováno v:
British Medical Bulletin. 53:798-816
In Europe, organ centres such as Bio Implant Services (BIS) in cooperation with Eurotransplant, play an intermediary role from donation of tissue and organs to allocation and transplantation. They take responsibility for donor medical/safety screenin
Publikováno v:
HSR Proceedings in Intensive Care & Cardiovascular Anesthesia
Introduction In the past 50 years, human cardiovascular tissue allografts, also called homografts, have been implanted into patients with different valvular diseases. The use of these allografts and the number of cardiovascular tissue banks and their
Publikováno v:
HSR Proceedings in Intensive Care & Cardiovascular Anesthesia
Ever since the early days of homograft implantation in 1956, and the introduction into clinical practice by Ross and Barrat Boyes, homograft heart valves have proven to have many advantages. Its disadvantages became evident during long-term follow up
Autor:
T M M H, de By
Publikováno v:
Developments in ophthalmology. 36
As there are plenty of potential corneal donors, theoretically there should be no shortage of corneal grafts. Practically, however, shortages have been a problem, especially with HLA-matched corneas, which are increasingly requested. This increase re
Autor:
T M M H de By
Background As there are plenty of potential corneal donors, theoretically there should be no shortage of corneal grafts. Practically, however, shortages have been a problem, especially with HLA-matched corneas, which are increasingly requested. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e95464c32b40af610f4fcd73a637e6dc
https://doi.org/10.1159/000067656
https://doi.org/10.1159/000067656